Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment

BACKGROUND: To evaluate the effect of systemic bevacizumab (Avastin®) therapy on pigment epithelial detachment (PED) secondary to age‐related macular degeneration (AMD) and to identify prognostic factors for PED regression and improvement in best corrected visual acuity (BCVA). STUDY DESIGN: Prospec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bolz, Matthias, Michels, Stephan, Geitzenauer, Wolfgang, Prager, Franz, Schmidt‐Erfurth, Ursula
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2007
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2266832/
https://ncbi.nlm.nih.gov/pubmed/17050580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.102467
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars